rs397514456
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM2PP2PP3PP5_Very_Strong
The NM_000516.7(GNAS):c.1174G>A(p.Glu392Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Genomes: not found (cov: 32)
Consequence
GNAS
NM_000516.7 missense
NM_000516.7 missense
Scores
9
7
3
Clinical Significance
Conservation
PhyloP100: 9.52
Genes affected
GNAS (HGNC:4392): (GNAS complex locus) This locus has a highly complex imprinted expression pattern. It gives rise to maternally, paternally, and biallelically expressed transcripts that are derived from four alternative promoters and 5' exons. Some transcripts contain a differentially methylated region (DMR) at their 5' exons, and this DMR is commonly found in imprinted genes and correlates with transcript expression. An antisense transcript is produced from an overlapping locus on the opposite strand. One of the transcripts produced from this locus, and the antisense transcript, are paternally expressed noncoding RNAs, and may regulate imprinting in this region. In addition, one of the transcripts contains a second overlapping ORF, which encodes a structurally unrelated protein - Alex. Alternative splicing of downstream exons is also observed, which results in different forms of the stimulatory G-protein alpha subunit, a key element of the classical signal transduction pathway linking receptor-ligand interactions with the activation of adenylyl cyclase and a variety of cellular reponses. Multiple transcript variants encoding different isoforms have been found for this gene. Mutations in this gene result in pseudohypoparathyroidism type 1a, pseudohypoparathyroidism type 1b, Albright hereditary osteodystrophy, pseudopseudohypoparathyroidism, McCune-Albright syndrome, progressive osseus heteroplasia, polyostotic fibrous dysplasia of bone, and some pituitary tumors. [provided by RefSeq, Aug 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), GNAS. . Gene score misZ 2.6546 (greater than the threshold 3.09). Trascript score misZ 4.8361 (greater than threshold 3.09). GenCC has associacion of gene with ACTH-independent macronodular adrenal hyperplasia 1, pseudohypoparathyroidism type 1B, pseudohypoparathyroidism type 1C, pseudohypoparathyroidism type 1A, progressive osseous heteroplasia, pseudopseudohypoparathyroidism, McCune-Albright syndrome.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.769
PP5
Variant 20-58910818-G-A is Pathogenic according to our data. Variant chr20-58910818-G-A is described in ClinVar as [Pathogenic]. Clinvar id is 29747.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-58910818-G-A is described in Lovd as [Likely_pathogenic]. Variant chr20-58910818-G-A is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GNAS | NM_080425.4 | c.3103G>A | p.Glu1035Lys | missense_variant | 13/13 | ENST00000371100.9 | NP_536350.2 | |
GNAS | NM_000516.7 | c.1174G>A | p.Glu392Lys | missense_variant | 13/13 | ENST00000371085.8 | NP_000507.1 | |
GNAS | NM_016592.5 | c.*1080G>A | 3_prime_UTR_variant | 13/13 | ENST00000371075.7 | NP_057676.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GNAS | ENST00000371100.9 | c.3103G>A | p.Glu1035Lys | missense_variant | 13/13 | 5 | NM_080425.4 | ENSP00000360141 | ||
GNAS | ENST00000371085.8 | c.1174G>A | p.Glu392Lys | missense_variant | 13/13 | 1 | NM_000516.7 | ENSP00000360126 | ||
GNAS | ENST00000371075.7 | c.*1080G>A | 3_prime_UTR_variant | 13/13 | 1 | NM_016592.5 | ENSP00000360115 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 21, 2020 | For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this variant affects GNAS protein function (PMID: 21488135). This variant has been observed in individual(s) with pseudohypoparathyroidism and pseudopseudohypoparathyroidism (PMID: 12970262, 21488135, 24651309, 21525160). ClinVar contains an entry for this variant (Variation ID: 29747). This variant is not present in population databases (ExAC no frequency). This sequence change replaces glutamic acid with lysine at codon 392 of the GNAS protein (p.Glu392Lys). The glutamic acid residue is highly conserved and there is a small physicochemical difference between glutamic acid and lysine. - |
Pathogenic, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Mar 10, 2015 | - - |
Pseudohypoparathyroidism type 1C Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jun 01, 2011 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Benign
T;.;.;T;.;.;T
Eigen
Uncertain
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;D;D;D;D;D
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D;D;D;D;D;D;D
MetaSVM
Uncertain
D
MutationAssessor
Benign
.;.;.;L;.;.;.
MutationTaster
Benign
D;D;D;D;D;D;D;D;D
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D;D;D;D;D;D;.
REVEL
Pathogenic
Sift
Uncertain
D;D;T;T;T;T;.
Sift4G
Uncertain
T;T;T;T;T;T;T
Polyphen
D;.;.;P;.;P;.
Vest4
MutPred
Gain of MoRF binding (P = 0);.;.;.;.;.;.;
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at